INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION - Image 1

£73.00

LAP Lambert Academic Publishing INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION

Name: INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION
Brand: LAP Lambert Academic Publishing
Price: 73.0 GBP
Availability: InStock

Subjects

Price data last checked 49 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 42 days • 42 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 42 days • 1 price levels

Days at Price

Price Analysis

Most common price: £73 (42 days, 100.0%)

Price range: £73 - £73

Price levels: 1 different prices over 42 days

Product Specifications

Brand: LAP Lambert Academic Publishing
Format: Paperback
ASIN: 6208447887
Category: Books > Subjects
Domain: Amazon UK
Release Date: 16 June 2025
Listed Since: 15 July 2025

Barcode

No barcode data available

LAP Lambert Academic Publishing INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION

Price History & Forecast

Price Distribution

Price Analysis

Product Specifications

Barcode

Similar Products You Might Like

TRIPS Agreement and Indian Pharmaceutical Industry: Emerging Firm Strategies and Economic Aspects of Affordability and Accessibility to Drugs

Financial Performance of Pharmaceutical Industry: In India

A Study of the Indian Pharmaceutical Industry in the New Patent Regime: Untangling Sources of Competitive Advantage in Unpredictable Environments

TRIPs and Indian Pharmaceautical Industry

Financial Performance Analysis of Pharmaceutical Enterprises in India: Financial Performance Analysis

Financial Performance of MNCs in Indian Pharmaceutical Industry: A Study during the Post-liberalisation Era

Total Quality Management Practices In Indian Pharmaceutical Industry: A Study on Selected Companies

PERFORMANCE EVALUATION OF SELECT INDIAN PHARMACEUTICAL COMPANIES: Analysis of Performance Evaluation of Pharmaceutical Companies- A Study of Select Companies in India

Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry: Productivity Growth, Technical Efficiency and Stochastic Production Function during Pre and Post-Merger Periods

Accounting For Intangible Assets: Research and Development Cost of Select Units

Capital Market Efficiency: Testing the Efficiency of Indian Capital Market with Respect to Pharmaceutical Industry

CRM Approaches used by Multinational & Indian Pharmaceutical Companies: Comparative Perception of Stakeholders-Global Perspective & Indian Context

The Indian Pharmaceutical Landscape: History, Current Standings, and, Future beyond 2025

Pharmaceutical Analysis of Some DPP-4 Inhibitors

INNOVATIVE MANAGEMENT PRACTICES IN UNCERTAIN TIMES: AN INDIAN PERSPECTIVE

Privatization and Financial Performance: An Indian Experience

Glimpses of HRD Practices: In Pharmaceuticals Companies

STRATEGIES OF MANAGING NON-PERFORMING ASSETS OF INDIAN BANKING SECTOR: Effectiveness of Strategies Adopted by Various Banks for NPA Management

Disclosure Practices in Indian Banking Sector: A Comparative Study

Non-Performing Assets (NPAs) in Indian Banks: Issues, Perspectives and Future Directions

Dossier submission process of drug product in USA, Europe and India: Dossier submission for drug product

Indian Spices: Delectable & Medicinal Values

Glimpses of Indian Medicinal Plants

Investor's Behavior In Indian Capital Market